Antineoplaston Therapy Cost Side Effects Explained

Antineoplaston Therapy Cost, Side Effects and Treatment Process

Antineoplaston Therapy Cost, Side Effects, and Treatment Process. How much does antineoplaston therapy cost? Learn about the ANP treatment process, reported side effects, monitoring, insurance issues, and questions cancer patients should ask.

If you are considering antineoplaston therapy (ANP) for cancer, three of the most practical questions are:

How much does antineoplaston therapy cost?
What side effects can antineoplastons cause?
What does the treatment process actually involve?

These questions are especially important because antineoplaston therapy is not a conventional FDA-approved cancer treatment. It has been studied for decades, primarily through research associated with Dr. Stanislaw Burzynski and the Burzynski Clinic/Research Institute in Houston, Texas.

I have a personal interest in antineoplaston therapy because ANP became part of my own cancer story. But personal experience—mine or anyone else’s—is not the same thing as clinical evidence.

I will say that while I can’t speak to other patients’ experiences at the BRI, the information below was thoroughly covered by the BRI when I first began my therapy. Further, I didn’t care that ANP wasn’t FDA-approved, and I didn’t care that the information I read wasn’t traditional clinical trials.

The purpose of this article is therefore not to tell you whether you should or should not pursue antineoplaston therapy.

It is to help you understand what you may be getting into medically, practically, and financially before making that decision.

Important: Antineoplastons are experimental and are not FDA-approved for the prevention or treatment of cancer. No randomized controlled trials demonstrating their effectiveness have been published in peer-reviewed medical journals.

If you have questions about ANP therapy, scroll down the page and post your question. I will reply to you ASAP.

Good luck,

David Emerson

Cancer Survivor
Cancer Coach
Director PeopleBeatingCancer

My Experience with Antineoplasteon Therapy as a Multiple Myeloma Patient

What Is Antineoplaston Therapy?

Antineoplastons are chemical compounds originally identified in human blood and urine by Stanislaw Burzynski, MD, PhD.

The compounds used therapeutically are now manufactured synthetically.

According to the National Cancer Institute (NCI), antineoplastons are mixtures involving amino-acid derivatives, peptides and amino acids. The principal preparations investigated in cancer patients have included A10 and AS2-1.

Dr. Burzynski proposed that antineoplastons function as part of a natural biochemical defense system that helps regulate abnormal cell growth and differentiation.

That theory remains controversial.

The NCI considers antineoplastons an experimental cancer therapy, and antineoplastons have not received FDA approval for treating cancer.

What Does Antineoplaston Treatment Involve?

Treatment protocols have varied considerably depending upon the cancer, clinical protocol, and time period.

Published clinical studies provide some insight into what patients receiving traditional ANP therapy have experienced.

1. Patient Evaluation

A patient considering treatment would generally require evaluation of:

cancer diagnosis
pathology
previous cancer treatments
current disease status
imaging studies
laboratory results
overall health
medications
previous treatment response

Patients considering any experimental cancer therapy should obtain copies of their complete medical records before consultation.

These may include:

pathology reports
CT, MRI or PET scans
treatment summaries
chemotherapy records
radiation records
operative reports
laboratory results

2. Determining Whether the Patient Is Eligible

Historically, much of the published research involving antineoplastons has involved patients with advanced or difficult-to-treat cancers, particularly brain tumors.

Eligibility for experimental therapy may depend upon such factors as:

cancer type
tumor characteristics
previous treatments
organ function
performance status
disease progression
availability of a clinical protocol

Patients should ask a particularly important question:

Am I receiving antineoplastons as part of an FDA-authorized clinical trial or another treatment program?

Do not assume that visiting a clinic automatically means you will receive antineoplastons.

How Are Antineoplastons Given?

Antineoplastons A10 and AS2-1 have historically been administered in relatively large doses.

Published clinical studies describe administration through methods including:

intravenous infusion
frequent dosing
infusion pumps
prolonged treatment schedules

Depending upon the protocol, treatment can therefore require considerably more daily management than taking an oral cancer medication.

Patients considering ANP should ask exactly:

How will my treatment be administered, how many hours per day will treatment require, and how long is the expected course of therapy?

Monitoring During Antineoplaston Therapy

Experimental cancer therapy should not mean unmonitored cancer therapy.

Patients receiving ANP may require periodic:

blood tests
electrolyte testing
kidney-function testing
liver-function testing
blood-pressure monitoring
neurologic evaluation
imaging

Imaging such as MRI or CT scans may be used to determine whether the cancer is:

shrinking
stable
progressing

Patients should know before beginning treatment how frequently these tests will be required and who is responsible for ordering and interpreting them.

What Are the Side Effects of Antineoplaston Therapy?

Antineoplastons are sometimes described as relatively nontoxic alternatives to chemotherapy.

That description can be misleading.

The National Cancer Institute reports that adverse effects associated with antineoplastons have ranged from mild symptoms to serious neurologic toxicity requiring discontinuation of treatment.

Reported adverse effects include:

Reported Side Effect	Possible Patient Experience
Anemia	Fatigue, weakness, shortness of breath
High blood pressure	Often asymptomatic; may require treatment
Abnormal blood calcium	Weakness, confusion or cardiac effects
Irregular heartbeat	Palpitations or cardiovascular symptoms
Headache	Mild to severe headaches
Dizziness	Balance problems or lightheadedness
Nausea/vomiting	Difficulty eating or maintaining hydration
Loss of appetite	Weight loss or nutritional problems
Skin rash/itching	Irritation or discomfort
Numbness	Neurologic symptoms
Fatigue/sleepiness	Reduced daily functioning
Peripheral edema	Swelling caused by fluid accumulation
Joint pain/stiffness	Mobility problems
Confusion	Neurologic toxicity
Seizures	Potentially serious neurologic complication
Cerebral edema	Swelling around the brain

The Neurologic Risks Deserve Special Attention

One NCI-sponsored phase II study involving patients with recurrent glioma reported neurological toxicity including:

excessive sleepiness
confusion
increased seizures
cerebral edema

Researchers also found that higher blood concentrations of phenylacetate were associated with central nervous system toxicity.

This is important.

ANP should not be thought of simply as a “natural treatment” without meaningful toxicity.

Experimental treatments can have serious side effects just as conventional cancer treatments can.

How Much Does Antineoplaston Therapy Cost?

This is one of the hardest questions to answer accurately.

Costs have changed considerably over the decades, and historical prices should not be interpreted as current prices.

For example, a 1999 review in CA: A Cancer Journal for Clinicians reported that antineoplaston treatment at that time could cost approximately:

$15,000-$30,000 per year.

That figure is now decades old and should not be used to estimate the cost of treatment today.

A patient considering treatment today should obtain a written, itemized estimate directly from the treating organization before committing to therapy.

The Real Cost May Be More Than the Drug

When evaluating ANP, I would not ask only:

“How much do antineoplastons cost?”

I would ask:

“What will the entire treatment process cost me?”

Potential expenses may include:

Expense	Questions to Ask
Initial consultation	Is there an evaluation fee?
Laboratory testing	How frequently will blood tests be required?
Imaging	Who pays for MRI, CT or PET scans?
Medication	Is ANP included in quoted treatment costs?
Infusion equipment	Is a pump or other equipment required?
Other medications	Are additional drugs prescribed?
Physician monitoring	Are follow-up visits billed separately?
Travel	How often must I travel to Houston?
Lodging	Will I need to stay near the clinic?
Caregiver expenses	Will someone need to travel with me?
Emergency care	Who pays if serious toxicity develops?
Long-term monitoring	How frequently must I return?

These additional costs can substantially change the financial impact of treatment.

Will Insurance Pay for Antineoplaston Therapy?

Patients should never assume that health insurance will pay for experimental cancer treatment.

Coverage can depend upon:

the treatment
clinical-trial status
insurance policy
diagnostic testing
physician services
imaging
laboratory testing
medications

Some conventional medical services associated with experimental treatment may be covered even when the experimental therapy itself is not.

The only way to know is to obtain written information from both the provider and your insurer.

Before paying anything, ask:

Which charges are expected to be covered by insurance and which charges will I personally be responsible for?

Whenever possible, obtain the answer in writing.

Questions I Would Ask Before Starting Antineoplaston Therapy

If I were evaluating ANP today, I would want clear answers to the following questions:

Am I actually receiving antineoplastons?
Am I entering an FDA-authorized clinical trial?
What specific ANP formulation will I receive?
How will it be administered?
How many hours each day will treatment require?
How long is treatment expected to continue?
What evidence exists for my specific cancer and stage?
How many patients like me have been treated?
What percentage experienced objective tumor responses?
How many experienced serious adverse events?
What laboratory monitoring will I need?
What happens if I develop neurologic symptoms?
What happens if my cancer progresses?
Can I continue conventional cancer treatment?
What is the total estimated cost of treatment?
Which costs are refundable if treatment stops?
Which expenses are likely to be covered by insurance?
Who will manage complications if I return home?

I would also ask for the answers to the financial questions in writing before paying substantial fees.

What Does the Evidence Say About Antineoplastons?

This is where patients need to separate three different issues:

whether individual patients have reported benefiting
whether published studies report responses
whether high-quality clinical evidence has demonstrated that the treatment works

These are not the same thing.

The National Cancer Institute states that:

no randomized controlled trials demonstrating effectiveness have been published in peer-reviewed medical journals;
most published clinical research has come from the developer of the therapy and colleagues;
other researchers have not successfully reproduced the reported results;
evidence supporting antineoplastons as a cancer treatment remains inconclusive.

That does not prove that no individual patient has ever benefited.

It does mean that medicine currently cannot reliably determine which patients might benefit, how frequently they benefit, or whether observed outcomes are actually caused by antineoplaston therapy.

That distinction is central to understanding ANP.

PeopleBeatingCancer Evidence Rating

Question	PBC Rating	Why
Laboratory rationale	🟡 Limited/Preliminary	Biological hypotheses and laboratory research exist
Human clinical evidence	🟠 Low	Primarily nonrandomized studies and case-series evidence
Independent replication	🔴 Very Low	Reported results have not been convincingly reproduced independently
Randomized controlled evidence	🔴 None established	No published randomized controlled trials demonstrating efficacy
FDA approval for cancer	🔴 No	Antineoplastons are not FDA-approved cancer treatments
Evidence of toxicity	🟢 Established	Mild through serious adverse effects have been documented

Overall PBC Evidence Rating: 🔴 Insufficient Clinical Evidence

This rating does not mean that every patient story should be dismissed.

It means that the quality of evidence is not strong enough to conclude that antineoplastons are an effective cancer treatment.

For PeopleBeatingCancer, that distinction matters.

Patient experiences can generate questions and hypotheses.

Controlled clinical evidence is what tells us whether a treatment reliably improves outcomes.

ANP Cost vs. Evidence: The Decision Patients Actually Face

For someone with advanced cancer, the decision is rarely academic.

The real decision may look something like this:

“My oncologist says my options are limited. I have found people online who say antineoplastons helped them. The treatment may be expensive. The evidence is uncertain. What do I do?”

There is no simple answer.

But I believe patients should evaluate four things simultaneously:

Factor	Question
Potential benefit	What credible evidence suggests this could help my cancer?
Risk	What are the possible serious side effects?
Financial toxicity	What will the entire treatment realistically cost?
Opportunity cost	What other treatment could I be receiving instead?

The fourth question may be the most overlooked.

Money is not the only limited resource.

Time is also a cancer patient’s resource.

If an experimental therapy requires weeks or months of treatment, the patient needs to understand what other treatments, clinical trials or supportive-care opportunities might be delayed or lost.

A Particularly Important Question: What Happens to My Conventional Treatment?

Patients considering ANP should discuss the decision with their medical oncologist.

Ask:

Would starting antineoplaston therapy require me to delay, stop or change a treatment that has demonstrated clinical benefit for my cancer?

This question changes the risk-benefit calculation substantially.

Using an experimental therapy after standard treatments have been exhausted is a very different decision from abandoning an effective standard treatment to pursue an unproven alternative.

My View as a Cancer Survivor

I understand why cancer patients investigate therapies outside conventional oncology.

When standard treatments offer limited options—or when those treatments have already failed—the phrase “there isn’t enough evidence” can feel unsatisfying.

Patients want options.

I certainly did.

But investigating unconventional cancer therapies requires us to hold two ideas in our heads simultaneously:

We should remain open to therapies that may eventually prove useful.

And:

We should demand good evidence before assuming that they work.

Those principles are not contradictory.

They are the foundation of evidence-based integrative oncology.

The Bottom Line

Antineoplaston therapy remains an experimental cancer treatment.

Patients considering it should understand three realities.

Cost:
Current total treatment costs are difficult to establish from reliable independent public sources. Obtain a detailed written estimate covering treatment, testing, monitoring, travel and follow-up before making a financial commitment.

Side effects:
Antineoplastons are not risk-free. Reported toxicities range from relatively mild symptoms to serious neurologic complications including confusion, seizures and cerebral edema.

Treatment process:
ANP therapy may involve substantial medical monitoring, frequent treatment administration, laboratory testing, imaging, and potentially significant travel and caregiver requirements.

Most importantly, patients should understand that antineoplastons have not been proven effective through randomized controlled clinical trials and are not FDA-approved cancer treatments.

For someone facing advanced cancer, exploring every reasonable option is understandable.

The goal should be to make that decision with as much information—and as few illusions—as possible.

Questions to Discuss With Your Oncologist

What evidence-based treatments are still available for my cancer?
Am I eligible for a clinical trial?
What is my prognosis with and without additional treatment?
Could ANP interfere with my current treatment?
What risks could occur if I delay conventional therapy?
Can you review the proposed ANP treatment plan with me?
What objective measurements should we use to determine whether treatment is working?

A good oncologist does not have to agree with every treatment you investigate.

But your oncologist should help you understand the medical consequences of your choices.

Research

NCI Antineoplastons — Patient Version
NCI Antineoplastons — Health Professional Version

Buckner JC, et al. — Phase II study of antineoplastons A10 and AS2-1 in patients with recurrent glioma. Mayo Clinic Proceedings. 1999.
An independent phase II study particularly important for understanding neurologic toxicity associated with ANP.

Cassileth BR — Evaluating complementary and alternative therapies for cancer patients. CA: A Cancer Journal for Clinicians. 1999.
Provides historical context regarding alternative cancer therapies and historical ANP treatment costs.

To Learn More About Antineoplaston Therapy:

To Learn More About Cancer Management:

Antineoplaston Therapy Cost, Side Effects Antineoplaston Therapy Cost, Side Effects Antineoplaston Therapy Cost, Side Effects Antineoplaston Therapy Cost, Side Effects Antineoplaston Therapy Cost, Side Effects

Our Mission